90 related articles for article (PubMed ID: 25533730)
1. Validity of participant-reported diagnoses in an online patient registry: a report from the NF1 Patient Registry Initiative.
Sharkey EK; Zoellner NL; Abadin S; Gutmann DH; Johnson KJ
Contemp Clin Trials; 2015 Jan; 40():212-7. PubMed ID: 25533730
[TBL] [Abstract][Full Text] [Related]
2. Development of an international internet-based neurofibromatosis Type 1 patient registry.
Johnson KJ; Hussain I; Williams K; Santens R; Mueller NL; Gutmann DH
Contemp Clin Trials; 2013 Mar; 34(2):305-11. PubMed ID: 23246715
[TBL] [Abstract][Full Text] [Related]
3. Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1.
Abadin SS; Zoellner NL; Schaeffer M; Porcelli B; Gutmann DH; Johnson KJ
J Pediatr; 2015 Sep; 167(3):613-20.e1-2. PubMed ID: 26028287
[TBL] [Abstract][Full Text] [Related]
4. Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1.
Porcelli B; Zoellner NL; Abadin SS; Gutmann DH; Johnson KJ
Fam Cancer; 2016 Apr; 15(2):301-8. PubMed ID: 26666764
[TBL] [Abstract][Full Text] [Related]
5. Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative.
Liu Q; Zoellner N; Gutmann DH; Johnson KJ
Fam Cancer; 2015 Jun; 14(2):317-24. PubMed ID: 25523354
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of participant recruitment methods to a rare disease online registry.
Johnson KJ; Mueller NL; Williams K; Gutmann DH
Am J Med Genet A; 2014 Jul; 164A(7):1686-94. PubMed ID: 24700441
[TBL] [Abstract][Full Text] [Related]
7. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
8. Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1.
Johnson KJ; Zoellner NL; Gutmann DH
Cancer Epidemiol; 2016 Jun; 42():53-9. PubMed ID: 27018750
[TBL] [Abstract][Full Text] [Related]
9. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
[TBL] [Abstract][Full Text] [Related]
10. Glomus tumors in individuals with neurofibromatosis type 1.
Kumar MG; Emnett RJ; Bayliss SJ; Gutmann DH
J Am Acad Dermatol; 2014 Jul; 71(1):44-8. PubMed ID: 24685357
[TBL] [Abstract][Full Text] [Related]
11. Validation of the NARCOMS registry: diagnosis.
Marrie RA; Cutter G; Tyry T; Campagnolo D; Vollmer T
Mult Scler; 2007 Jul; 13(6):770-5. PubMed ID: 17525097
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic significance of unilateral Lisch nodules.
Ceuterick SD; Van Den Ende JJ; Smets RM
Bull Soc Belge Ophtalmol; 2005; (295):49-53. PubMed ID: 15849989
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of neurofibromatosis type 1 progression using a nationwide registry of patients who submitted claims for medical expense subsidies in Japan between 2008 and 2012.
Yamauchi T; Suka M; Nishigori C; Yanagisawa H
Orphanet J Rare Dis; 2019 Jul; 14(1):166. PubMed ID: 31277677
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis Clinic: A Report on Patient Demographics and Evaluation of the Clinic.
Mansouri A; Ghadakzadeh S; Maqbool T; Barnett C; Au K; Kongkham P; Bril V; Gelareh Z
Can J Neurol Sci; 2017 Sep; 44(5):577-588. PubMed ID: 27821212
[TBL] [Abstract][Full Text] [Related]
15. National registry diagnoses agree with medical records on hospitalized asthmatic children.
Moth G; Vedsted P; Schiøtz PO
Acta Paediatr; 2007 Oct; 96(10):1470-3. PubMed ID: 17727688
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
[TBL] [Abstract][Full Text] [Related]
17. Nevus Anemicus As an Additional Diagnostic Marker of Neurofibromatosis Type 1 in Childhood.
Vaassen P; Rosenbaum T
Neuropediatrics; 2016 Jun; 47(3):190-3. PubMed ID: 27019377
[TBL] [Abstract][Full Text] [Related]
18. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
[TBL] [Abstract][Full Text] [Related]
19. Silver-Russell syndrome-like features in a patient carrying a novel NF1 mutation.
Wimmer K; Decker M; Mayatepek E; Beiglböck H; Eggermann T; Kehrer-Sawatzki H; Fonatsch C; Rosenbaum T
Pediatr Res; 2005 Dec; 58(6):1265-8. PubMed ID: 16306205
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
